Advertisement
Advertisement
NAUT
Nautilus Biotechnolgy, Inc. Common Stock
0.97
USDSponsored
-0.01
-0.59%
Sep 18, 15:59 UTC -4
Closed
After-Market
0.97
+0.01
+0.72%
NAUT Earnings Reports
Positive Surprise Ratio
NAUT beat 19 of 21 last estimates.
90%
Next Report
Date of Next Report
Oct 26, 2026
Estimate for Q3 26 (Revenue/ EPS)
$212.50K
/-$0.14
Implied change from Q2 26 (Revenue/ EPS)
+11.84%
/+27.27%
Implied change from Q3 25 (Revenue/ EPS)
--
/+27.27%
Nautilus Biotechnolgy, Inc. Common Stock earnings per share and revenue
On Jul 28, 2026, NAUT reported earnings of -0.11 USD per share (EPS) for Q2 26, beating the estimate of -0.13 USD, resulting in a 20.12% surprise. Revenue reached 190.00 thousand, compared to an expected --, with a 0.00% difference. The market reacted with a -27.71% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.14 USD, with revenue projected to reach 212.50 thousand USD, implying an increase of 27.27% EPS, and increase of 11.84% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Sep 08, 2026 For Q3 26
Estimate
-$0.43
Actual
-$0.47
Surprise
-7.16%
Anixa Biosciences, Inc.
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+8.78%
Alzamend Neuro, Inc. Common Stock
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.57
Actual
-$0.68
Surprise
-19.05%
FAQ
What were Nautilus Biotechnolgy, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Nautilus Biotechnolgy, Inc. Common Stock reported EPS of -$0.11, beating estimates by 20.12%, and revenue of $190.00K, 0% as expectations.
How did the market react to Nautilus Biotechnolgy, Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -27.71%, changed from $1.66 before the earnings release to $1.20 the day after.
When is Nautilus Biotechnolgy, Inc. Common Stock expected to report next?
The next earning report is scheduled for Oct 26, 2026.
What are the forecasts for Nautilus Biotechnolgy, Inc. Common Stock's next earnings report?
Based on 4
analysts, Nautilus Biotechnolgy, Inc. Common Stock is expected to report EPS of -$0.14 and revenue of $212.50K for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.